| The Cardiovascular Health Study (CHS) was founded in 1988, with additional baseline samples taken in 1992, is an observational study of risk factors for cardiovascular disease in adults 65 years or older (n=5888, age range 65-100). Genotyping was performed at the University of Texas Health Science Center using the ABITaqMan platform. |
| This analysis of association between genotype and incident heart failure was conducted in the setting of the Cardiovascular Health Study among 574 African-American participants (367 women and 207 men) who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over anaverage of 10.1 years of follow-up, 135 participants experienced an incident heart failure. Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip. |
| The Cardiovascular Health Study (CHS) was founded in 1988, with additional baseline samples taken in 1992, is an observational study of risk factors for cardiovascular disease in adults 65 years or older (n=5888, age range 65-100). Genotyping was performed at the University of Texas Health Science Center using the ABI TaqMan platform. |
| This analysis of association between genotype and incident heart failure was conducted in the setting of the Cardiovascular Health Study among 3295 participants (2005 women and 1290 men) of primarily self-described European ancestry who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over an average of 11.8 years of follow-up, 838 participants experienced an incident heart failure. Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip., |
| This analysis of association between genotype and incident stroke was conducted in the setting of the Cardiovascular Health Study among 574 African-American participants who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over an average of 9.9 years of follow-up, 85 participants experienced an incident stroke(68 ischemic, 12 hemorrhagic, and 5 of unknown subtype).Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip. |
| The Cardiovascular Health Study (CHS) was founded in 1988, with additional baseline samples taken in 1992, is an observational study of risk factors for cardiovascular disease in adults 65 years or older (n=5888, age range 65-100). Genotyping was performed at the University of Texas Health Science Center using the ABI TaqMan platform. |
| This analysis of association between genotype and incident stroke was conducted in the setting of the Cardiovascular Health Study among 3291 participants of primarily self-described European ancestry who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over an average of 11.7 years of follow-up, 500 participants experienced an incident stroke (405 ischemic, 61 hemorrhagic, 34 unknown subtype). Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip. |
| This analysis of association between genotype and incident myocardial infarction was conducted in the setting of the Cardiovascular Health Study among 574 African-American participants (367 women and 207 men) who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over an average of 10.5 years of follow-up, 74 participants experienced an incident myocardial infarction. Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip. |
| The Cardiovascular Health Study (CHS) was founded in 1988, with additional baseline samples taken in 1992, is an observational study of risk factors for cardiovascular disease in adults 65 years or older (n=5888, age range 65-100). Genotyping was performed at the University of Texas Health Science Center using the ABI TaqMan platform. |
| This analysis of association between genotype and incident myocardial infarction was conducted in the setting of the Cardiovascular Health Study among 3291 participants (2003 women and 1288 men) of primarily self-described European ancestry who were free of clinical cardiovascular disease at baseline, consented to use of their DNA for cardiovascular research, and were successfully genotyped on the Illumina 370 CNV platform. Over an average of 12 years of follow-up, 537 participants experienced an incident myocardial infarction. Genotyping was conducted at General Clinical Research Center’s Phenotyping/Genotyping Laboratory at Cedars-Sinai using the Illumina 370CNV Genotyping Beadchip. |